155 related articles for article (PubMed ID: 9861300)
1. Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs.
Choussat R; Hittinger L; Barbe F; Maistre G; Carayon A; Crozatier B; Su J
Cardiovasc Res; 1998 Sep; 39(3):580-8. PubMed ID: 9861300
[TBL] [Abstract][Full Text] [Related]
2. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure.
Shimoyama H; Sabbah HN; Borzak S; Tanimura M; Shevlyagin S; Scicli G; Goldstein S
Circulation; 1996 Aug; 94(4):779-84. PubMed ID: 8772702
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
[TBL] [Abstract][Full Text] [Related]
4. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.
Kiowski W; Sütsch G; Hunziker P; Müller P; Kim J; Oechslin E; Schmitt R; Jones R; Bertel O
Lancet; 1995 Sep; 346(8977):732-6. PubMed ID: 7658874
[TBL] [Abstract][Full Text] [Related]
5. Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure.
Su J; Renaud N; Carayon A; Crozatier B; Hittinger L
Br J Pharmacol; 1994 Oct; 113(2):395-402. PubMed ID: 7834190
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous endothelin-1 in experimental renal hypertension in dogs.
Donckier J; Stoleru L; Hayashida W; Van Mechelen H; Selvais P; Galanti L; Clozel JP; Ketelslegers JM; Pouleur H
Circulation; 1995 Jul; 92(1):106-13. PubMed ID: 7788903
[TBL] [Abstract][Full Text] [Related]
7. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs.
Teerlink JR; Carteaux JP; Sprecher U; Löffler BM; Clozel M; Clozel JP
Am J Physiol; 1995 Jan; 268(1 Pt 2):H432-40. PubMed ID: 7840293
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure.
Himura Y; Liang CS; Imai N; Delehanty JM; Woolf PD; Hood WB
J Am Coll Cardiol; 1994 Jan; 23(1):194-200. PubMed ID: 8277081
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
Udvary E; Papp JG; Végh A
Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
[TBL] [Abstract][Full Text] [Related]
10. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects.
Wilson JR; Douglas P; Hickey WF; Lanoce V; Ferraro N; Muhammad A; Reichek N
Circulation; 1987 Apr; 75(4):857-67. PubMed ID: 3829344
[TBL] [Abstract][Full Text] [Related]
11. Regional alterations of left ventricular contraction and inotropic reserve in conscious dogs with heart failure.
Su JB; Barbe F; Laplace M; Crozatier B; Hittinger L
Cardiovasc Res; 1995 Dec; 30(6):848-56. PubMed ID: 8746198
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of indices of left ventricular contractility and relaxation in evolving canine experimental heart failure.
Moe GW; Angus C; Howard RJ; Parker TG; Armstrong PW
Cardiovasc Res; 1992 Apr; 26(4):362-6. PubMed ID: 1638568
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure.
Moe GW; Grima EA; Howard RJ; Seth R; Armstrong PW
Cardiovasc Res; 1994 Jan; 28(1):66-71. PubMed ID: 8111794
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat.
Li XS; Wang QD; Pernow J
Eur J Pharmacol; 1995 Sep; 283(1-3):161-8. PubMed ID: 7498305
[TBL] [Abstract][Full Text] [Related]
16. Effects of the non-peptide, non-selective endothelin antagonist, bosentan, on regional haemodynamic responses to NG-monomethyl-L-arginine in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 May; 118(2):352-4. PubMed ID: 8735637
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.
Weber C; Schmitt R; Birnboeck H; Hopfgartner G; van Marle SP; Peeters PA; Jonkman JH; Jones CR
Clin Pharmacol Ther; 1996 Aug; 60(2):124-37. PubMed ID: 8823230
[TBL] [Abstract][Full Text] [Related]
18. Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure.
McMahon WS; Holzgrefe HH; Walker JD; Mukherjee R; Arthur SR; Cavallo MJ; Child MJ; Spinale FG
J Am Coll Cardiol; 1996 Aug; 28(2):495-505. PubMed ID: 8800131
[TBL] [Abstract][Full Text] [Related]
19. Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan.
Hocher B; Rohmeiss P; Diekmann F; Zart R; Vogt V; Schiller S; Bauer C; Koppenhagen K; Distler A; Gretz N
Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):463-72. PubMed ID: 8547428
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
van Woerkens LJ; van der Giessen WJ; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
